Pulkoski-Gross, Michael J <br/><br/>
Novel sphingosine kinase-1 inhibitor, LCL351, reduces immune responses in murine DSS-induced colitis.  [electronic resource] 

 -  Prostaglandins & other lipid mediators  05 2017 
 - 47-56 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S. 
<br/><br/><label>ISSN: </label>1098-8823 
<br/><br/><label>Standard No.: </label>10.1016/j.prostaglandins.2017.03.006  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>A549 Cells<br/>Chemokine CXCL1--genetics<br/>Chemokine CXCL2--genetics<br/>Colitis--chemically induced<br/>Dextran Sulfate--adverse effects<br/>Gene Expression Regulation--drug effects<br/>Guanidines--pharmacology<br/>Humans<br/>Phosphotransferases (Alcohol Group Acceptor)--antagonists & inhibitors<br/>Sphingosine--pharmacology<br/>Tumor Necrosis Factor-alpha--genetics